Society for Inherited Metabolic Disorders Annual Meeting
Society for Inherited Metabolic Disorders Annual Meeting
批准号:
10091318
负责人:
NICOLA LONGO
金额:
$1.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-14 至 2023-01-31
关键词:
AffectAgeAmericanAreaArthritisAwardBiochemistryBlindnessBrazilCerebral PalsyChildClinicalClinical TrialsCongressesCountryDiabetes MellitusDiseaseEnzymesFailureFloridaFundingGenesGenomicsGoalsGrowthHeart DiseasesHepaticInborn Errors of MetabolismIndividualInheritedIntellectual functioning disabilityInternationalKnowledgeLocationMedical GeneticsMental RetardationMetabolic DiseasesMinorityMolecularNeonatal ScreeningNeuromuscular DiseasesPathway interactionsPatient CarePatientsPharmaceutical PreparationsPhysiciansPrivatizationRare DiseasesRecruitment ActivityResearchResearch PersonnelScholarshipSocietiesSourceSpecialistTimeTrainingTravelUnited States National Institutes of HealthVariantWashingtonWomandesigneffective therapyefficacy evaluationexomegenome sequencingkidney dysfunctionmedical schoolsmeetingsnovel therapeuticsscreening programsymposiumwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The Society for Inherited Metabolic Disorders (SIMD) requests support to provide scholarships for trainees to
attend its annual meetings in years 2016 to 2020. The 2016 meeting will be held in Ponte Vedra Beach,
Florida, on April 3-6, 2016. The 2017 meeting will be held in conjunction with the International Congress on
Inborn Errors of Metabolism in Rio de Janeiro, Brazil, September 5-8, 2017. The 2018 meeting will be held in
San Diego, CA, March 11-14, 2018. The 2019 Meeting will be held in coordination with the American College
of Medical Genetics in Seattle, Washington. The 2020 meeting will be held in a location to be determined in the
USA. Inborn errors of metabolism (IEM) are an important cause of intellectual disability, cerebral palsy,
neuromuscular disease, cardiac disorders, hepatic and renal dysfunction, arthritis, diabetes, growth failure and
blindness. These conditions affect people of all ages, but children are disproportionately affected. The clinical
and molecular spectrum of these disorders continues to expand, in part fueled by the rapid expansion of
newborn screening programs with the identification of milder cases and advances in genomics (exome and
whole genome sequencing) that identify patients at the most severe end of the spectrum. New therapies are
becoming available for some conditions, with still relatively few clinical trials to identify new therapies for
previously untreatable conditions. Much remains to be done to better understand these severe, rare disorders
and to develop effective treatments for them. For the U.S. to remain pre-eminent in this important area of
research, it is essential to attract young investigators into the field. One effective mechanism to achieve this
goal is to provide them with the opportunity to participate in the SIMD meeting, where they can explore the field
and develop scientific ties to other established investigators. The SIMD meeting is held annually and
participation, especially by young investigators, has been steadily increasing each year. The availability of NIH
travel awards has been a major reason for this increase. Trainees seeking funding are required to submit an
abstract describing original research to be presented at the meeting. Trainees/young investigators usually
submit about 30 abstracts for presentation at each meeting with twice that number for the international
meeting (2017). Applications for travel awards will be competitively reviewed 3 months prior to each meeting,
with the goal of making up to 15 annual awards of $ 1,000 each for the national meeting and up to 10 awards
of $ 1,500 for the International meeting. Additional funds will be solicited from private sources. Women and
minority applicants will be actively recruited.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Research Pilot Project Program
-
批准号:10481863
-
项目类别:
-
资助金额:$8.79万
-
财政年份:2019
-
负责人:NICOLA LONGO
-
依托单位:
Clinical Research Pilot Project Program
-
批准号:10701019
-
项目类别:
-
资助金额:$8.79万
-
财政年份:2019
-
负责人:NICOLA LONGO
-
依托单位:
Clinical Research Pilot Project Program
-
批准号:10260446
-
项目类别:
-
资助金额:$8.79万
-
财政年份:2019
-
负责人:NICOLA LONGO
-
依托单位:
Clinical Research Pilot Project Program
-
批准号:10019408
-
项目类别:
-
资助金额:$9.51万
-
财政年份:2019
-
负责人:NICOLA LONGO
-
依托单位:
Society for Inherited Metabolic Disorders Annual Meeting
-
批准号:7893627
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2009
-
负责人:NICOLA LONGO
-
依托单位:
Society for Inherited Metabolic Disorders Annual Meeting
-
批准号:8386831
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2009
-
负责人:NICOLA LONGO
-
依托单位:
Society for Inherited Metabolic Disorders Annual Meeting
-
批准号:8610332
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2009
-
负责人:NICOLA LONGO
-
依托单位:
Society for Inherited Metabolic Disorders Annual Meeting
-
批准号:8520360
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:NICOLA LONGO
-
依托单位:
Society for Inherited Metabolic Disorders Annual Meeting
-
批准号:9258206
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2009
-
负责人:NICOLA LONGO
-
依托单位:
Society for Inherited Metabolic Disorders Annual Meeting
-
批准号:7749902
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2009
-
负责人:NICOLA LONGO
-
依托单位:
NON-INVASIVE BLOOD PHENYLALANINE MONITOR
-
批准号:7718494
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:NICOLA LONGO
-
依托单位:
Anaplerotic therapy in Propionic Acidemia
-
批准号:7315111
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2007
-
负责人:NICOLA LONGO
-
依托单位:
NON-INVASIVE BLOOD PHENYLALANINE MONITOR
-
批准号:7604952
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2007
-
负责人:NICOLA LONGO
-
依托单位:
Anaplerotic therapy in Propionic Acidemia
-
批准号:7486316
-
项目类别:
-
资助金额:$18.44万
-
财政年份:2007
-
负责人:NICOLA LONGO
-
依托单位:
NON-INVASIVE BLOOD PHENYLALANINE MONITOR
-
批准号:7376432
-
项目类别:
-
资助金额:$0.19万
-
财政年份:2006
-
负责人:NICOLA LONGO
-
依托单位:
MUTANT INSULIN REC IN GROWTH RESTRICTION
-
批准号:6586039
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:NICOLA LONGO
-
依托单位:
MUTANT INSULIN REC IN GROWTH RESTRICTION
-
批准号:6565744
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:NICOLA LONGO
-
依托单位:
CARNITINE TRANSPORTER IN HUMAN DISEASE
-
批准号:6535161
-
项目类别:
-
资助金额:$17.61万
-
财政年份:2000
-
负责人:NICOLA LONGO
-
依托单位:
THE CARNITINE TRANSPORTER IN HUMAN DISEASE
-
批准号:7250062
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2000
-
负责人:NICOLA LONGO
-
依托单位:
CARNITINE TRANSPORTER IN HUMAN DISEASE
-
批准号:6381115
-
项目类别:
-
资助金额:$2.04万
-
财政年份:2000
-
负责人:NICOLA LONGO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: